Company intelligence / Profile preview

Bridgewest Perth

Perth, Western Australia, Australia

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Bridgewest Perth is a premier contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceutical products. The company operates a sophisticated manufacturing facility in Perth, Australia, which was acquired from Pfizer in 2023. Bridgewest Perth provides a comprehensive suite of services including formulation development, analytical testing, and commercial-scale aseptic filling for both small molecules and biologics. The facility is TGA and FDA approved, positioning it as a critical hub for high-quality pharmaceutical production in the Asia-Pacific region.

Modalities: Small moleculeBiologicVaccineSterile injectables
Industry: Contract Manufacturing Organization

Partnerships

Pfizer

Beyond the preview

Go deeper on Bridgewest Perth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bridgewest Perth.

Explore the full profile